Takeshi Takayasu

Takeshi Takayasu

Auto-generated profile, based on publicly available information

Takeshi Takayasu

Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2006 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
TTTakeshi Takayasu
Takeshi Takayasu
FYFumiyuki Yamasaki
Fumiyuki Yamasaki
ATAtsushi Tominaga
Atsushi Tominaga
THToshikazu Hidaka
Toshikazu Hidaka
KAKazunori Arita
Kazunori Arita
KKKaoru Kurisu
Kaoru Kurisu

28 December 2020 in Neurosurgery
Verified
Journal Article
Closed access
ADAntonio Dono
Antonio Dono
TTTakeshi Takayasu
Takeshi Takayasu
Yuanqing YanYuanqing Yan
Yuanqing Yan
BBBethany E Bundrant
Bethany E Bundrant
OAOctavio Arevalo
Octavio Arevalo
LBLeomar Y Ballester
Leomar Y Ballester
BACKGROUND: Brain metastases (BMs) occur in ∼1/3 of cancer patients and are associated with poor prognosis. Genomic alterations contribute to BM development; however, mutations that predispose and promote BM development are poorly understood.OBJECTIVE: To identify differences in genomic alterations between BM and primary tumors.METHODS: A retrospective cohort of 144 BM patients were tested for genomic alterations (85 lung, 21 breast, 14 melanoma, 4 renal, 4 colon, 3 prostate, 4 others, and 9 unknown carcinomas) by a next-generation sequencing assay interrogating 315 genes. The differences in genomic alterations between BM and primary tumors from COSMIC and TCGA were evaluated by chi-square or Fisher's exact test. Overall survival curves were plotted using the Kaplan-Meier method.RESULTS: The comparison of BM and primary tumors revealed genes that were mutated in BM with increased frequency:TP53, ATR, andAPC(lung adenocarcinoma);ARID1AandFGF10(lung small-cell);PIK3CG, NOTCH3, andTET2(lung squamous);ERBB2, BRCA2, andAXL1(breast carcinoma);CDKN2A/B, PTEN, RUNX1T1, AXL, andFLT4(melanoma); andATM, AR, CDKN2A/B, TERT, andTSC1(renal clear-cell carcinoma). Moreover, our results indicate that lung adenocarcinoma BM patients withCREBBP, GPR124, orSPTA1mutations have a worse prognosis. Similarly,ERBB2, CDK12, orTP53mutations are associated with worse prognosis in breast cancer BM patients.CONCLUSION: The present study demonstrates significant differences in the frequency of mutations between primary tumors and BM and identifies targetable alterations and genes that correlate with prognosis. Identifying the genomic alterations that are enriched in metastatic central nervous system tumors could help our understanding of BM development and improve patient management.

1 January 2012 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
PDF file
TTTakeshi Takayasu
Takeshi Takayasu
KHKunyu Harada
Kunyu Harada
SNShigeru Nishimura
Shigeru Nishimura
JOJun Onda
Jun Onda
TNTohru Nishi
Tohru Nishi
HTHisashi Takagaki
Hisashi Takagaki
Arachnoid cysts are well known to induce chronic subdural hematoma (CSDH) after head injury. However, histological observations of the arachnoid cyst and hematoma membrane have only been rarely described. An 8-year-old boy and a 3-year-old boy presented with CSDH associated with arachnoid cyst. Surgical removal of the hematoma and biopsy of the hematoma membrane and cyst wall were performed. Clinical courses were good and without recurrence more than 1.5 years after surgery. Histological examination suggested that the cysts did not contribute to hematoma development. Pediatric hematoma membranes, similar to adult hematoma membranes, are key in the growth of CSDH. Therefore, simple hematoma evacuation is adequate as a first operation for CSDH associated with arachnoid cyst.

15 December 2022 in Japanese Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
YMYugo Maeda
Yugo Maeda
SOShumpei Onishi
Shumpei Onishi
FYFumiyuki Yamasaki
Fumiyuki Yamasaki
TTTakeshi Takayasu
Takeshi Takayasu
UYUshio Yonezawa
Ushio Yonezawa
NHNobutaka Horie
Nobutaka Horie
Secondary meningioma after cranial irradiation, so-called radiation-induced meningioma, is one of the important late effects after cranial radiation therapy. In this report, we analyzed our case series of secondary meningioma after cranial irradiation and conducted a critical review of literature to reveal the characteristics of secondary meningioma. We performed a comprehensive literature review by using Pubmed, MEDLINE and Google scholar databases and investigated pathologically confirmed individual cases. In our institute, we found pathologically diagnosed seven cases with secondary meningioma between 2000 and 2018. Totally, 364 cases were analyzed based on gender, WHO grade, radiation dose, chemotherapy. The latency years from irradiation to development of secondary meningioma were analyzed with Kaplan–Meier analysis. Spearman’s correlation test was used to determine the relationship between age at irradiation and the latency years. The mean age at secondary meningioma development was 35.6 ± 15.7 years and the mean latency periods were 22.6 ± 12.1 years. The latency periods from irradiation to the development of secondary meningioma are significantly shorter in higher WHO grade group (P = 0.0026, generalized Wilcoxon test), higher radiation dose group (P < 0.0001) and concomitant systemic chemotherapy group (P = 0.0003). Age at irradiation was negatively associated with the latency periods (r = −0.23231, P < 0.0001, Spearman’s correlation test). Cranial irradiation at older ages, at higher doses and concomitant chemotherapy was associated with a shorter latency period to develop secondary meningiomas. However, even low-dose irradiation can cause secondary meningiomas after a long latency period. Long-term follow-up is necessary to minimize the morbidity and mortality caused by secondary meningioma after cranial irradiation.

1 April 2018 in European Journal of Radiology
Verified
Journal Article
Closed access
TTTakeshi Takayasu
Takeshi Takayasu
FYFumiyuki Yamasaki
Fumiyuki Yamasaki
YAYuji Akiyama
Yuji Akiyama
MOMegu Ohtaki
Megu Ohtaki
TSTaiichi Saito
Taiichi Saito
KKKaoru Kurisu
Kaoru Kurisu

1 February 2022 in World Neurosurgery
Verified
Journal Article
Open access
ATAkira Taguchi
Akira Taguchi
YKYasuyuki Kinoshita
Yasuyuki Kinoshita
VAVishwa Jeet Amatya
Vishwa Jeet Amatya
TTTakeshi Takayasu
Takeshi Takayasu
MTMotoki Takano
Motoki Takano
FYFumiyuki Yamasaki
Fumiyuki Yamasaki
Endoscopic third ventriculostomy (ETV) for obstructive hydrocephalus and endoscopic biopsy (EB) for intraventricular and paraventricular tumors are standard therapies because they are minimally invasive procedures. Although EB-associated hemorrhagic risk has been well documented, there have been only a few reports on hemorrhagic risk associated with ETV. We conducted a single-institution retrospective study on the incidence of hemorrhage secondary to EB and/or ETV. We retrospectively reviewed patient characteristics, procedure, pathological findings, and complications including hemorrhage of 100 patients with intraventricular and paraventricular tumors who underwent EB and/or ETV at our institution from 2000 to 2020. EB/ETV combined surgery (combined group), EB-alone surgery (EB-alone group), and ETV-alone surgery (ETV-alone group) were performed in 44 (44%), 24 (24%), and 32 (32%) patients, respectively, and all procedures were successful. The rates of definitive and suggestive diagnoses in EB were 76.5% and 23.5%, respectively. Adverse events were observed in 6 patients. In the combined group, acute obstruction of the ETV stoma was observed in 1 patient and transient double vision was observed in 1 patient. Transient aqueductal stenosis/obstruction was observed in 2 patients in the EB-alone group. In the ETV-alone group, hemorrhage was observed in 2 patients; these patients developed intratumoral hemorrhage despite ETV-alone surgery. Subsequently, these 2 patients underwent tumor removal, and the histopathological diagnosis was atypical teratoid/rhabdoid tumor in both. For obstructive hydrocephalus with atypical teratoid/rhabdoid tumor, physicians must be aware of the risk of postoperative intratumoral hemorrhage after performing ETV.